Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Mouse Anti-Mouse CXCL9 (Mig) Monoclonal Antibodies
Case ID:
TAB-2173
Web Published:
12/6/2022
This technology describes monoclonal antibodies against mouse chemokine (C-X-C motif) ligand 9 (CXCL9), also known as Monokine induced by gamma interferon (Mig). CXCL9 is a secreted protein that functions to attract white cells and increased expression of CXCL9 has been linked to several diseases. The inventors at the NIH generated over 100 anti-mouse CXCL9 antibodies from a CLXL9/Mig knockout mouse and further characterized several antibodies to show neutralization of CXCL9. As such, these antibodies could be used to measure concentrations of mouse CLXL9 in laboratory samples and block the activity of CXCL9 in injected mice. These antibodies are suitable for ELISA and Western blot. The antibodies have not been tested in flow cytometry or immunohistochemistry, but may also be useful for these applications.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Mouse_Anti-Mouse_CXCL9_(Mig) _Monoclonal_Antibodies
Keywords:
antibodies
Anti-mouse
AXXXXX
CCXXXX
CXCL9
CXXXXX
IA3XXX
IAXXXX
IDXXXX
IXXXXX
MIG
monoclonal
Mouse
Bookmark this page
Download as PDF
For Information, Contact:
Charles Rainwater
Technology Development Specialist
NIH Technology Transfer
301-496-5717
crainwater@mail.nih.gov